| Style | Citing Format |
|---|---|
| MLA | Simonian M, Mosallayi M, Mirzaei H. "Circulating Mir-21 As Novel Biomarker in Gastric Cancer: Diagnostic and Prognostic Biomarker." Journal of Cancer Research and Therapeutics, vol. 14, no. 2, 2018, pp. 475-. |
| APA | Simonian M, Mosallayi M, Mirzaei H (2018). Circulating Mir-21 As Novel Biomarker in Gastric Cancer: Diagnostic and Prognostic Biomarker. Journal of Cancer Research and Therapeutics, 14(2), 475-. |
| Chicago | Simonian M, Mosallayi M, Mirzaei H. "Circulating Mir-21 As Novel Biomarker in Gastric Cancer: Diagnostic and Prognostic Biomarker." Journal of Cancer Research and Therapeutics 14, no. 2 (2018): 475-. |
| Harvard | Simonian M, Mosallayi M, Mirzaei H (2018) 'Circulating Mir-21 As Novel Biomarker in Gastric Cancer: Diagnostic and Prognostic Biomarker', Journal of Cancer Research and Therapeutics, 14(2), pp. 475-. |
| Vancouver | Simonian M, Mosallayi M, Mirzaei H. Circulating Mir-21 As Novel Biomarker in Gastric Cancer: Diagnostic and Prognostic Biomarker. Journal of Cancer Research and Therapeutics. 2018;14(2):475-. |
| BibTex | @article{ author = {Simonian M and Mosallayi M and Mirzaei H}, title = {Circulating Mir-21 As Novel Biomarker in Gastric Cancer: Diagnostic and Prognostic Biomarker}, journal = {Journal of Cancer Research and Therapeutics}, volume = {14}, number = {2}, pages = {475-}, year = {2018} } |
| RIS | TY - JOUR AU - Simonian M AU - Mosallayi M AU - Mirzaei H TI - Circulating Mir-21 As Novel Biomarker in Gastric Cancer: Diagnostic and Prognostic Biomarker JO - Journal of Cancer Research and Therapeutics VL - 14 IS - 2 SP - 475 EP - PY - 2018 ER - |